The page is the record's research on the issuer — no analyst, no rating, no view.

PRISM BioLab Co.,LTD (206A) — research page

JP · jp-cm-kg/TSE-GROWTH/206A · as of 2026-11-06

Identity and listing

The issuer is PRISM BioLab Co.,LTD, listed on the Growth Market under ticker 206A. Its ISIN and LEI are not on the record. Its security type is Corporate, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its segment is not on the record. The issuer is listed and not halted.

fieldvaluesource · read date
namePRISM BioLab Co.,LTDsource · 2026-11-06
exchangeGrowth Marketsource · 2026-11-06
ticker206Asource · 2026-11-06
ISINnot on the record
LEInot on the record
security typeCorporatesource · 2026-11-06
segmentnot on the record
sector3250 Pharmaceuticalsource · 2026-11-06
jurisdictionJapan (EDINET domestic filer)source · 2026-11-06
statuslisted, not haltedsource · 2026-11-08

The disclosure read

The record holds 6 filings in the window 2025-11-06 to 2026-11-06, across 2 filing days. Of these, 1 is ad hoc, 3 are regulatory filings and 2 are results. The median gap between filing days is 141 days. The latest filing is dated 2026-05-14 and is a regulatory filing, 176 days before the record date of 2026-11-06. The Growth Market median cadence gap is 42 days across 598 issuers, with a median of 8.0 filings and a median latency of 85.0 days. The 3250 Pharmaceutical sector median cadence gap is 49.5 days across 80 issuers, with a median of 8.0 filings and a median latency of 85.0 days.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer6141176
exchange median: Growth Market (598 issuers)84285
sector median: 3250 Pharmaceutical (80 issuers)849.585
datetypecategoryfiling
2026-05-14regulatory_filing135確認書
2026-05-14results半期報告書 (half-year report)半期報告書-第15期(2025/10/01-2026/09/30)
2025-12-24ad_hoc臨時報告書 (extraordinary report)臨時報告書
2025-12-24regulatory_filing235内部統制報告書-第14期(2024/10/01-2025/09/30)
2025-12-24regulatory_filing135確認書

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows the issuer as listed, not halted.

Orderability

For Qualified Institutional Investors the outcome is not determinable. The rule states a product scope, the subject's class carries no CFI to place on the scope bridge, and no scope object names the class, so the subject is not shown within the scope. The signal is null. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04.

client categoryoutcome
Qualified Institutional Investorsnot determinable: the rule states a product scope; the subject's class carries no CFI to place on the scope bridge, and no scope object names the class: the subject is not shown within the scope

rule acm-68000/jp/suitability-principle-fiea-article-40/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

No research houses were found on the issuer's investor-relations pages read.

Open research

One openly published research note is on the record, from The Stock Research Center, dated 2024-07-05.

datepublishernotekind
2024-07-05The Stock Research CenterPRISM BioLab (206A TSE Growth) Newly Listed Company Introduction Reportindependent

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the date the live record began is not on the record.

Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
10.2
https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
10.3
https://mcp.jp-cm-kg.ai/events/TSE-GROWTH/206A (the disclosure lines)
10.4
https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
10.5
https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XCIN (the auditor)
10.6
https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://holistic-r.org/adm/wp-content/uploads/2024/07/211A240719_en.pdf (open research)
10.8
https://mcp.jp-cm-kg.ai/record/TSE-GROWTH/206A (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"ticker":"206A","exchange":"Growth Market"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:17778b2f2f9f4946.